Samsara BioCapital GP, LLC, Ten Percent Owner at Scholar Rock Holding, holds 5.67M shares in Mineralys Therapeutics, Inc. (Ticker: MLYS), holds 206.78K shares in vTv Therapeutics (Ticker: VTVT), holds 1.72M shares in Neurogene (Ticker: NGNE). Most recently, Samsara BioCapital GP, LLC Bought ― shares of Mineralys Therapeutics, Inc. on Mar 17, 2025 for an estimated value of 8.10M.
What was Samsara BioCapital GP, LLC’s latest transaction?
Samsara BioCapital GP, LLC latest transaction was an Informative Buy of $8.10M.
What was Samsara BioCapital GP, LLC's most profitable transaction?
Samsara BioCapital GP, LLC’s most profitable transaction was an Informative Buy of SRRK stock on October 18, 2023. The return on the trade was 306.20%.
What is Samsara BioCapital GP, LLC's role in Scholar Rock Holding?
Samsara BioCapital GP, LLC's role in Scholar Rock Holding is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.